Why we’re needed

In many countries, more men die from prostate cancer than women die from breast cancer

Prostate cancer is the most common cancer in men over the age of 50 in Europe. In 2018 it killed 107,000 men in Europe – the equivalent to a full Airbus 300 each week. Many more men are suffering a devastating loss in their quality of life from the treatments for later stages of prostate cancer. Today more men die from prostate cancer than women die from breast cancer.

The main issues affecting men with prostate cancer in Europe are:

  • late diagnosis
  • treatment inconsistencies
  • poor quality of life
  • lack of information and support
Prostate cancer is the most common cancer in men over the age of 50

Late diagnosis

Unlike breast cancer, there are no screening programmes for prostate cancer in Europe. We campaign for a Europe-wide PSA-based programme, which research shows could save 20,000 men’s lives.

Read more about screening

Treatment inconsistencies

Treatment of prostate cancer is variable between European countries and within countries. We talk to politicians in Europe to raise their awareness of the issues and impose standards.

Read more about better treatment

Poor quality of life after treatment

Treatments for prostate cancer can leave men with many life-limiting effects. We are researching these impacts and campaigning for better support

Read more about quality of life

Lack of information and support

Men with prostate cancer can be left isolated and lacking information. We nurture and encourage prostate cancer patient support groups around Europe.

Read more about support groups